Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

Which of the statements about the use of tumor necrosis factor inhibitors for managing rheumatic disorders are correct?

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...

Find the best tech you can buy right now, chosen by experts at Engadget.